Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells

Nanomedicine

Volumn 9, Issue 8, 2014, Pages 1209-1222

  Chen, Wenxue ^a,b   Ayala Orozco, Ciceron ^c   Biswal, Nrusingh C ^a   Perez Torres, Carlos ^a   Bartels, Marc ^a   Bardhan, Rizia ^c   Stinnet, Gary ^a   Liu, Xian De ^d   Ji, Baoan ^e   Deorukhkar, Amit ^d   Brown, Lisa V ^c   Guha, Sushovan ^d   Pautler, Robia G ^a   Krishnan, Sunil ^d   Halas, Naomi J ^c,f   Joshi, Amit ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c RICE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e MAYO GRADUATE SCHOOL   (United States)

^f Rice University   (United States)

Author keywords

MRI; nanoshells; noninvasive imaging; optical imaging; pancreatic cancer; photothermal

Indexed keywords

GOLD NANOPARTICLE; INDOCYANINE GREEN; IRON OXIDE; NANOSHELL; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN ANTIBODY; PROTEIN ANTIBODY; SILICON DIOXIDE; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; CONTRAST MEDIUM; FLUORESCENT DYE; GOLD; LCN2 PROTEIN, MOUSE; LIPOCALIN; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DEATH; FEMALE; IN VITRO STUDY; MOUSE; NANOENCAPSULATION; NONHUMAN; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN INTERACTION; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; FLUORESCENCE IMAGING; HUMAN; MAGNET; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PANCREAS; PANCREATIC NEOPLASMS; PATHOLOGY; PHOTOTHERAPY; THERMOTHERAPY; TUMOR CELL LINE;

ACUTE-PHASE PROTEINS; ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCENT DYES; GOLD; HUMANS; HYPERTHERMIA, INDUCED; LIPOCALINS; MAGNETIC RESONANCE IMAGING; MAGNETS; MICE, NUDE; NANOSHELLS; ONCOGENE PROTEINS; OPTICAL IMAGING; PANCREAS; PANCREATIC NEOPLASMS; PHOTOTHERAPY;

EID: 84906283393     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.84     Document Type: Article

References (42)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin. 58(2), 71-96 (2008).
2. Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100, 313 patients diagnosed from 1985-1995, using the national cancer database. J. Am. Coll. Surg. 189(1), 1-7 (1999).
3. Krishnan S, Rana V, Janjan NA et al. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer 107(11), 2589-2596 (2006).
4. Krishnan S, Rana V, Janjan NA et al. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal beneft from consolidative chemoradiation therapy. Cancer 110(1), 47-55 (2007).
5. Bafna S, Kaur S, Momi N, Batra SK. Pancreatic cancer cells resistance to gemcitabine: the role of muc4 mucin. Brit. J. Cancer 101(7), 1155-1161 (2009).
6. Yang L, Mao H, Cao Z et al. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology 136(5), 1514.e2-1525.e2 (2009).
7. Chen Y, Bathula SR, Li J, Huang L. Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer. J. Biol. Chem. 285(29), 22639-22650 (2010).
8. Gultepe E, Reynoso FJ, Jhaveri A et al. Monitoring of magnetic targeting to tumor vasculature through MRI and biodistribution. Nanomedicine (Lond.) 5(8), 1173-1182 (2010).
9. Dreaden EC, MacKey MA, Huang X, Kang B, El-Sayed MA. Beating cancer in multiple ways using nanogold. Chem. Soc. Rev. 40(7), 3391-3404 (2011).
10. Bardhan R, Lal S, Joshi A, Halas NJ. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Accounts Chem. Res. 44(10), 936-946 (2011).
11. Chen W, Bardhan R, Bartels M et al. A molecularly targeted theranostic probe for ovarian cancer. Mol. Cancer Ther. 9(4), 1028-1038 (2010).
12. Bardhan R, Chen W, Bartels M et al. Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo. Nano Lett. 10(12), 4920-4928 (2010).
13. Bardhan R, Chen W, Perez-Torres C et al. Nanoshells with targeted simultaneous enhancement of magnetic and optical imaging and photothermal therapeutic response. Adv. Func. Mater. 19(24), 3901-3909 (2009).
14. Argani P, Rosty C, Reiter RE et al. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res. 61(11), 4320-4324 (2001).
15. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD. Identifcation of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 62(10), 2890-2896 (2002).
16. Iacobuzio-Donahue CA, Ashfaq R, Maitra A et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profles obtained from three major technologies. Cancer Res. 63(24), 8614-8622 (2003).
17. Laurell H, Bouisson M, Berthelémy P et al. Identifcation of biomarkers of human pancreatic adenocarcinomas by expression profling and validation with gene expression analysis in endoscopic ultrasound-guided fne needle aspiration samples. World J. Gastroenterol. 12(21), 3344-3351 (2006).
18. Missiaglia E, Blaveri E, Terris B et al. Analysis of gene expression in cancer cell lines identifes candidate markers for pancreatic tumorigenesis and metastasis. Int. J. Cancer 112(1), 100-112 (2004).
19. Moniaux N, Chakraborty S, Yalniz M et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Brit. J. Cancer 98(9), 1540-1547 (2008).
20. Furutani M, Arii S, Mizumoto M, Kato M, Imamura M. Identifcation of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modifed signal sequence trap method. Cancer Lett. 122(1-2), 209-214 (1998).
21. Tong Z, Kunnumakkara AB, Wang H et al. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res. 68(15), 6100-6108 (2008).
22. Roy R, Louis G, Loughlin KR et al. Tumor-specifc urinary matrix metalloproteinase fngerprinting: identifcation of high molecular weight urinary matrix metalloproteinase species. Clin. Cancer Res. 14(20), 6610-6617 (2008).
23. Iannetti A, Pacifco F, Acquaviva R et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-icB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc. Natl Acad. Sci. USA 105(37), 14058-14063 (2008).
24. Lim R, Ahmed N, Borregaard N et al. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int. J. Cancer 120(11), 2426-2434 (2007).
25. Hu L, Hittelman W, Lu T et al. NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab. Invest. 89(5), 531-548 (2009).
26. Yang J, Bielenberg DR, Rodig SJ et al. Lipocalin 2 promotes breast cancer progression. Proc. Natl Acad. Sci. USA 106(10), 3913-3918 (2009).
27. Leng X, Ding T, Lin H et al. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res. 69(22), 8579-8584 (2009).
28. Hwang K, Houston JP, Rasmussen JC et al. Improved excitation light rejection enhances small-animal fuorescent optical imaging. Mol. Imaging 4(3), 194-204 (2005).
29. Gad SC, Sharp KL, Montgomery C, Payne JD, Goodrich GP. Evaluation of the toxicity of intravenous delivery of auroshell particles (gold-silica nanoshells). Int. J. Toxicol. 31(6), 584-594 (2012).
30. Terentyuk GS, Maslyakova GN, Suleymanova LV et al. Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery. J. Biophotonics 2(5), 292-302 (2009).
31. James WD, Hirsch LR, West JL, O'Neal PD, Payne JD. Application of INAA to the build-up and clearance of gold nanoshells in clinical studies in mice. J. Radioanal. Nucl. Chem. 271(2), 455-459 (2007).
32. Sengelov H, Boulay F, Kjeldsen L, Borregaard N. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem. J. 299(2), 473-479 (1994).
33. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and infammatory bowel diseases. Gut 38(3), 414-420 (1996).
34. Bratt T, Ohlson S, Borregaard N. Interactions between neutrophil gelatinase-associated lipocalin and natural lipophilic ligands. Biochim. Biophys. Acta 1472(1-2), 262-269 (1999).
35. Schmidt-Ott KM, Mori K, Jau YL et al. Dual action of neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol. 18(2), 407-413 (2007).
36. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94(6), 2493-2503 (1994).
37. Gough PJ, Gomez IG, Wille PT, Raines EW. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-defcient mice. J. Clin. Invest. 116(1), 59-69 (2006).
38. Loftus IM, Naylor AR, Goodall S et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques: a potential role in acute plaque disruption. Stroke 31(1), 40-47 (2000).
39. Te Boekhorst BC, Bovens SM, Hellings WE et al. Molecular MRI of murine atherosclerotic plaque targeting NGAL: a protein associated with unstable human plaque characteristics. Cardiovascular Res. 89(3), 680-688 (2011).
40. Ghaneh P, Costello E, Neoptolemos JP. Biology and management of pancreatic cancer. Postgrad. Med. J. 84(995), 478-497 (2008).
41. Schwartzberg AM, Olson TY, Talley CE, Zhang JZ. Synthesis, characterization, and tunable optical properties of hollow gold nanospheres. J. Phys. Chem. B 110 (40), 19935-19944 (2006).
42. Bardhan R, Mukherjee S, Mirin NA, Levit SD, Nordlander P, Halas NJ. Nanosphere-in-a-nanoshell: a simple nanomatryushka. J. Phys. Chem. C 114(16), 7378-7383 (2010).